Here's Won't Touch Teva: Why I Pass on the Generic Giant
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Benchmarks help you measure performance. This intro explains which indices serve as benchmarks and how investors use them to compare risk and return.
20,611 articlesTeva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
With burnout on the rise in early 2026, workers seek structured ways to reduce load without leaving their jobs. Inves...
A Wayfair founder sold shares worth about $2.1 million in February 2026. This article breaks down what insider sellin...
Morgan Stanley stock sank after news of a private credit fund imposing withdrawal caps. This article breaks down the ...
A seasoned investor quietly built a multi-million stake in a fast-moving chemicals firm. This article breaks down the...
Analysts see Elon Musk's Terafab strategy as a potential catalyst for chip-equipment makers and select chip stocks, b...
The Nasdaq Composite extended gains as bulls maintain control amid stronger tech deal activity, improving chip profit...
Investors flooded crypto funds with $858M in inflows as lawmakers push a clarity-focused framework for stablecoins. T...
Berkshire Hathaway just resumed stock buybacks after a long pause, signaling a shift in capital allocation. This arti...
The Kiplinger Letter argues that most GDP growth celebrated in Washington isn’t driven by AI, a claim with sharp impl...
As inflation remains stubborn, a prominent podcast host argues that sitting on cash erodes real buying power. Investo...
A heated AI race has intensified as Google doubles down on AI integration amid OpenAI momentum. Critics raise a provo...